The Wegovy tablet’s ‘shock miss’ is one cause Novo Nordisk’s inventory is down

This text was initially printed by MarketWatch.com – High Tales. The title and a quick excerpt are supplied for informational and reference functions. Readers ought to go to the unique writer for the whole article, supporting context, photos, and any subsequent updates.

The Danish drugmaker additionally revealed an improved outlook for the yr.

The unique publication comprises the whole reporting and ought to be consulted for the total textual content and any further info.

Classes:

Tags:

Read the Original Article →